The pattern no single source sees

Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Company or person27

Biofrontera Inc.

Company

4 records in the corpus

BiomX Inc.

Company

23 records in the corpus

BIOGEN INC.

Company

4 records in the corpus

Natera, Inc.

Company

25 records in the corpus

BIOVIE INC.

Company

13 records in the corpus

KYNTRA BIO, INC.

Company

7 records in the corpus

BioAtla, Inc.

Company

7 records in the corpus

GRI Bio, Inc.

Company

4 records in the corpus

Q32 Bio Inc.

Company

9 records in the corpus

BLUE BIOFUELS, INC.

Company

5 records in the corpus

TRex Bio, Inc.

Company

15 records in the corpus

BioCorRx Inc.

Company

1 records in the corpus

Onterris, Inc.

Company

3 records in the corpus

Instil Bio, Inc.

Company

1 records in the corpus

KALA BIO, Inc.

Company

7 records in the corpus

BIODESIX INC

Company

6 records in the corpus

BIOLARGO, INC.

Company

9 records in the corpus

Inmune Bio, Inc.

Company

5 records in the corpus

TELA Bio, Inc.

Company

16 records in the corpus

BIOMERICA INC

Company

9 records in the corpus

Climb Bio, Inc.

Company

10 records in the corpus

BIOXYTRAN, INC

Company

2 records in the corpus

Frontdoor, Inc.

Company

8 records in the corpus

Korro Bio, Inc.

Company

12 records in the corpus

BioCardia, Inc.

Company

16 records in the corpus

Bioventus Inc.

Company

3 records in the corpus

BELITE BIO, INC

Company

8 records in the corpus

Primary record3

Biofrontera Inc. filed 25-NSE

0001354457-26-001041.txt : 20261030 25-NSE 1 primary_doc.xml X0203 0001354457 Nasdaq Stock Market LLC 0001858685 Biofrontera Inc. 001-40943 120 Presidential Way, Suite 330 Woburn MA MASSACHUSETTS 01801 781-245-1325 warra

30 Oct 2026 · sec daily index

Biofrontera Inc. filed 8-K

Item 8.01 Other Events. On September 14, 2026, Biofrontera Inc. (the Company ) issued a press release announcing that it has received notification from the U.S. Food and Drug Administration (the FDA ) that the FDA had ap

14 Sep 2026 · sec daily index

Biofrontera Inc. filed 8-K

Item 2.02 Results of Operations and Financial Condition . On August 13, 2026, Biofrontera Inc. (the Company ) issued a press release announcing its financial and operational results for the three and six months ended Jun

13 Aug 2026 · sec daily index